255 related articles for article (PubMed ID: 24892647)
1. Shaking alone induces de novo conversion of recombinant prion proteins to β-sheet rich oligomers and fibrils.
Ladner-Keay CL; Griffith BJ; Wishart DS
PLoS One; 2014; 9(6):e98753. PubMed ID: 24892647
[TBL] [Abstract][Full Text] [Related]
2. Formation of soluble oligomers and amyloid fibrils with physical properties of the scrapie isoform of the prion protein from the C-terminal domain of recombinant murine prion protein mPrP-(121-231).
Martins SM; Frosoni DJ; Martinez AM; De Felice FG; Ferreira ST
J Biol Chem; 2006 Sep; 281(36):26121-8. PubMed ID: 16844683
[TBL] [Abstract][Full Text] [Related]
3. Amyloid formation by recombinant full-length prion proteins in phospholipid bicelle solutions.
Lührs T; Zahn R; Wüthrich K
J Mol Biol; 2006 Mar; 357(3):833-41. PubMed ID: 16466741
[TBL] [Abstract][Full Text] [Related]
4. A simple in vitro assay for assessing the efficacy, mechanisms and kinetics of anti-prion fibril compounds.
Ladner-Keay CL; Ross L; Perez-Pineiro R; Zhang L; Bjorndahl TC; Cashman N; Wishart DS
Prion; 2018; 12(5-6):280-300. PubMed ID: 30223704
[TBL] [Abstract][Full Text] [Related]
5. Autocatalytic conversion of recombinant prion proteins displays a species barrier.
Baskakov IV
J Biol Chem; 2004 Feb; 279(9):7671-7. PubMed ID: 14668351
[TBL] [Abstract][Full Text] [Related]
6. Evidence for stepwise formation of amyloid fibrils by the mouse prion protein.
Jain S; Udgaonkar JB
J Mol Biol; 2008 Oct; 382(5):1228-41. PubMed ID: 18687339
[TBL] [Abstract][Full Text] [Related]
7. Disease-associated F198S mutation increases the propensity of the recombinant prion protein for conformational conversion to scrapie-like form.
Vanik DL; Surewicz WK
J Biol Chem; 2002 Dec; 277(50):49065-70. PubMed ID: 12372829
[TBL] [Abstract][Full Text] [Related]
8. Protein misfolding cyclic amplification induces the conversion of recombinant prion protein to PrP oligomers causing neuronal apoptosis.
Yuan Z; Yang L; Chen B; Zhu T; Hassan MF; Yin X; Zhou X; Zhao D
J Neurochem; 2015 Jun; 133(5):722-9. PubMed ID: 25810062
[TBL] [Abstract][Full Text] [Related]
9. Detailed biophysical characterization of the acid-induced PrP(c) to PrP(β) conversion process.
Bjorndahl TC; Zhou GP; Liu X; Perez-Pineiro R; Semenchenko V; Saleem F; Acharya S; Bujold A; Sobsey CA; Wishart DS
Biochemistry; 2011 Feb; 50(7):1162-73. PubMed ID: 21189021
[TBL] [Abstract][Full Text] [Related]
10. Annealing prion protein amyloid fibrils at high temperature results in extension of a proteinase K-resistant core.
Bocharova OV; Makarava N; Breydo L; Anderson M; Salnikov VV; Baskakov IV
J Biol Chem; 2006 Jan; 281(4):2373-9. PubMed ID: 16314415
[TBL] [Abstract][Full Text] [Related]
11. In vitro conversion of full-length mammalian prion protein produces amyloid form with physical properties of PrP(Sc).
Bocharova OV; Breydo L; Parfenov AS; Salnikov VV; Baskakov IV
J Mol Biol; 2005 Feb; 346(2):645-59. PubMed ID: 15670611
[TBL] [Abstract][Full Text] [Related]
12. Slow spontaneous α-to-β structural conversion in a non-denaturing neutral condition reveals the intrinsically disordered property of the disulfide-reduced recombinant mouse prion protein.
Sang JC; Lee CY; Luh FY; Huang YW; Chiang YW; Chen RP
Prion; 2012; 6(5):489-97. PubMed ID: 22987112
[TBL] [Abstract][Full Text] [Related]
13. Pathway complexity of prion protein assembly into amyloid.
Baskakov IV; Legname G; Baldwin MA; Prusiner SB; Cohen FE
J Biol Chem; 2002 Jun; 277(24):21140-8. PubMed ID: 11912192
[TBL] [Abstract][Full Text] [Related]
14. On the mechanism of alpha-helix to beta-sheet transition in the recombinant prion protein.
Morillas M; Vanik DL; Surewicz WK
Biochemistry; 2001 Jun; 40(23):6982-7. PubMed ID: 11389614
[TBL] [Abstract][Full Text] [Related]
15. Assembly of the full-length recombinant mouse prion protein I. Formation of soluble oligomers.
Vendrely C; Valadié H; Bednarova L; Cardin L; Pasdeloup M; Cappadoro J; Bednar J; Rinaudo M; Jamin M
Biochim Biophys Acta; 2005 Aug; 1724(3):355-66. PubMed ID: 15975719
[TBL] [Abstract][Full Text] [Related]
16. Copper(II) inhibits in vitro conversion of prion protein into amyloid fibrils.
Bocharova OV; Breydo L; Salnikov VV; Baskakov IV
Biochemistry; 2005 May; 44(18):6776-87. PubMed ID: 15865423
[TBL] [Abstract][Full Text] [Related]
17. High pressure induces scrapie-like prion protein misfolding and amyloid fibril formation.
Torrent J; Alvarez-Martinez MT; Harricane MC; Heitz F; Liautard JP; Balny C; Lange R
Biochemistry; 2004 Jun; 43(22):7162-70. PubMed ID: 15170353
[TBL] [Abstract][Full Text] [Related]
18. Dissection of conformational conversion events during prion amyloid fibril formation using hydrogen exchange and mass spectrometry.
Singh J; Udgaonkar JB
J Mol Biol; 2013 Sep; 425(18):3510-21. PubMed ID: 23811055
[TBL] [Abstract][Full Text] [Related]
19. N-terminal domain of prion protein directs its oligomeric association.
Trevitt CR; Hosszu LL; Batchelor M; Panico S; Terry C; Nicoll AJ; Risse E; Taylor WA; Sandberg MK; Al-Doujaily H; Linehan JM; Saibil HR; Scott DJ; Collinge J; Waltho JP; Clarke AR
J Biol Chem; 2014 Sep; 289(37):25497-508. PubMed ID: 25074940
[TBL] [Abstract][Full Text] [Related]
20. Role of polysaccharide and lipid in lipopolysaccharide induced prion protein conversion.
Ladner-Keay CL; LeVatte M; Wishart DS
Prion; 2016 Nov; 10(6):466-483. PubMed ID: 27906600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
